IMRIS to hold third quarter 2009 results conference call

WINNIPEG , Oct. 27 /CNW/ - IMRIS Inc. (TSX: IM) Third Quarter 2009

    
    -------------------------------------------------------------------------
    Earnings Release                    November 2, 2009 (after market close)
    -------------------------------------------------------------------------
    Conference Call and Webcast         November 3, 2009, 8:30 a.m. ET
    -------------------------------------------------------------------------
    Hosted by                           David Graves, Chairman, President and
                                        Chief Executive Officer;
                                        Kelly McNeill, Executive Vice
                                        President, Finance and Chief
                                        Financial Officer
    -------------------------------------------------------------------------
    Participant Numbers                 416-644-3414 or 1-800-814-4859
    -------------------------------------------------------------------------
    Conference Call ID Number           4167500
    -------------------------------------------------------------------------
    

A question and answer session for analysts and institutional investors will follow management's presentation. A taped rebroadcast will be available to listeners until 12 a.m. on November 9, 2009 . To access the rebroadcast, please dial 416-640-1917 or 1-877-289-8525 and enter the passcode 4167500 followed by the number sign.

About IMRIS

IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced imaging solutions that incorporate multiple imaging modalities including magnetic resonance and fluoroscopy to deliver timely information to clinicians during surgical or interventional procedures. The Company's systems utilize patented technology that allows a high field MR scanner to be moved in to the operating room on demand, providing imaging during the surgical or interventional procedure without compromising patient safety. The Company's flagship product, IMRISneuro, has been validated by leading neurosurgeons and is in use at neuroscience centers around the world.

For further information: Brad Woods, Director Investor Relations & Corporate Communications, IMRIS Inc., [phone], [email protected], www.imris.com